Form 4: Ultragenyx Pharmaceutical CFO Sells Shares
Insider Transaction (Form 4)
Howard Horn, Chief Financial Officer of Ultragenyx Pharmaceutical Inc., sold 4,696 shares of common stock on August 3, 2026 for $24.92 per share.
Summary
- Open-market sale: disposed of 4,696 Common Stock at $24.92 ($117,024) on August 3, 2026; holds 96,295 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $117,024 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Howard Horn — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market sale | Common Stock | 4,696 | $25 | $117.0K | 96,295 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market sale (4,696 shares) |
Keywords
insider transaction, Form 4, RARE, Ultragenyx Pharmaceutical Inc., bearish, Howard Horn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.